Longer times from symptom onset to randomization equaled a smaller—or perhaps no—advantage for Impella vs standard care.

A new study published in the journal of PloS One showed that although reoperative therapy with evolocumab with rosuvastatin ...

A new study finds that patients who suffer a STEMI heart attack while hospitalized are 10 times more likely to die than patients who suffer a STEMI outside the hospital. If you suffer a heart attack ...

Please provide your email address to receive an email when new articles are posted on . Long-term follow-up from DANAMI-3-PRIMULTI shows reduction in events after complete revascularization vs.

India, Jan. 25 -- Concept Medical Inc, a global developer of drug-delivery technologies for cardiovascular interventions, has ...

Hospitals that implemented key processes of care as part of a broad American Heart Association (AHA) STEMI initiative over just a few years’ time had reperfusion times comparable to those seen in ...

It's best to have patients on aggressive lipid-lowering therapy before discharge after an acute ST-segment elevation myocardial infarction (STEMI), so why not start it right away — even in the cath ...

Operators safely shaved a few minutes off heart attack reperfusion times by taking patients straight to culprit lesion percutaneous coronary intervention (PCI) when they arrived at the catheterization ...

A 50-year-old man comes to your emergency department at 11:00 PM to visit his mother, a patient in your care. Suddenly he develops substernal chest pressure radiating bilaterally across his chest. He ...